143 related articles for article (PubMed ID: 17803893)
1. Which pharmacovigilance for vaccines?
Le Louët H; Loupi E; Haramburu F;
Therapie; 2007; 62(3):241-7. PubMed ID: 17803893
[TBL] [Abstract][Full Text] [Related]
2. Which Pharmacovigilance for Vaccines?
Le Louët H; Loupi E; Haramburu F;
Therapie; 2007; 62(3):245-7. PubMed ID: 27393410
[TBL] [Abstract][Full Text] [Related]
3. [Vaccines pharmacovigilance].
Autret-Leca E; Jonville-Béra AP; Beau-Salinas F
Rev Prat; 2004 Mar; 54(5):526-31. PubMed ID: 15176512
[TBL] [Abstract][Full Text] [Related]
4. Statistical, epidemiological, and risk-assessment approaches to evaluating safety of vaccines throughout the life cycle at the Food and Drug Administration.
Ball R; Horne D; Izurieta H; Sutherland A; Walderhaug M; Hsu H
Pediatrics; 2011 May; 127 Suppl 1():S31-8. PubMed ID: 21502249
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacovigilance of vaccines].
Autret-Leca E; Bensouda-Grimaldi L; Jonville-Béra AP; Beau-Salinas F
Arch Pediatr; 2006 Feb; 13(2):175-80. PubMed ID: 16343870
[TBL] [Abstract][Full Text] [Related]
6. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
7. [Essential to monitor vaccine safety].
Heijbel H
Lakartidningen; 2001 Sep; 98(36):3777-8. PubMed ID: 11586806
[TBL] [Abstract][Full Text] [Related]
8. Methods of ensuring vaccine safety.
Ball R
Expert Rev Vaccines; 2002 Aug; 1(2):161-8. PubMed ID: 12901555
[TBL] [Abstract][Full Text] [Related]
9. Field evaluation of vaccine safety.
Tozzi AE
Vaccine; 2004 May; 22(15-16):2091-5. PubMed ID: 15121330
[TBL] [Abstract][Full Text] [Related]
10. Technologies that make administration of vaccines safer.
Clements CJ; Larsen G; Jodar L
Vaccine; 2004 May; 22(15-16):2054-8. PubMed ID: 15121322
[TBL] [Abstract][Full Text] [Related]
11. [Sanitary risk: medicinal products and medical devices].
Marimbert J
Rev Prat; 2005 Nov; 55(18):2026-32. PubMed ID: 16419907
[TBL] [Abstract][Full Text] [Related]
12. [Adverse reaction surveillance system for vaccination in the Republic of Cuba].
Galindo Santana BM; Galindo Sardiña MA; Pérez Rodríguez A
Rev Cubana Med Trop; 1999; 51(3):194-200. PubMed ID: 10887588
[TBL] [Abstract][Full Text] [Related]
13. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
Souayah N; Nasar A; Suri MF; Qureshi AI
J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
[TBL] [Abstract][Full Text] [Related]
14. [Dengue fever: from disease to vaccination].
Teyssou R
Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
[TBL] [Abstract][Full Text] [Related]
15. Post Launch Monitoring of food products: what can be learned from pharmacovigilance.
van Puijenbroek EP; Hepburn PA; Herd TM; van Grootheest AC
Regul Toxicol Pharmacol; 2007 Mar; 47(2):213-20. PubMed ID: 17204356
[TBL] [Abstract][Full Text] [Related]
16. [Misuse of drugs: conclusions of the pharmacovigilance workshops at La Baule, France].
Fermont I;
Therapie; 2002; 57(3):283-8. PubMed ID: 12422543
[TBL] [Abstract][Full Text] [Related]
17. A call for international harmonization in therapeutic risk management.
Hirst C; Cook S; Dai W; Perez-Gutthann S; Andrews E
Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):839-49; discussion 850-1. PubMed ID: 16981215
[TBL] [Abstract][Full Text] [Related]
18. Generics and substitution modalities: proposed methods for the evaluation of equivalence, traceability and pharmacovigilance reporting.
Lamarque V; Merle L; Demarez JP;
Therapie; 2008; 63(4):301-9. PubMed ID: 18937910
[TBL] [Abstract][Full Text] [Related]
19. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
20. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
